文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
Katharine Burton
发表
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
J. Haughney, V. Libri, M. Kamal, 2022, The Lancet Infectious Diseases.